# C_2015032EN.01000101.xml

| 30.1.2015 | EN | Official Journal of the European Union | C 32/1 |
| --- | --- | --- | --- |

30.1.2015

EN

Official Journal of the European Union

C 32/1

---

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 December 2014 to 31 December 2014

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))

1

(2015/C 032/01)

—   Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Issuing of a marketing authorisation

Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorisation | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 5.12.2014 | Paliperidone Janssen | Paliperidone | Janssen-Cilag International NV
  Turnhoutseweg 30, B-2340 Beerse, België | EU/1/14/971 | Prolonged release suspension for injection | N05AX13 | 9.12.2014 |
| 8.12.2014 | Duloxetine Lilly | Duloxetine | Eli Lilly Nederland B.V.
  Grootslag 1-5, NL-3991 RA Houten, Nederland | EU/1/14/972 | Gastro-resistant capsule, hard | N06AX21 | 10.12.2014 |
| 8.12.2014 | Moventig | Naloxegol | AstraZeneca AB
  SE-151 85 Södertälje, Sverige | EU/1/14/962 | Film-coated tablet | A06AH03 | 10.12.2014 |
| 16.12.2014 | DUAVIVE | Oestrogens conjugated/bazedoxifene | Pfizer Limited
  Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom | EU/1/14/960 | Modified-release tablet | G03CX | 18.12.2014 |
| 16.12.2014 | Lynparza | Olaparib | AstraZeneca AB
  SE-151 85 Södertälje, Sverige | EU/1/14/959 | Capsule, hard | L01 | 18.12.2014 |
| 19.12.2014 | Cyramza | Ramucirumab | Eli Lilly Nederland B.V.
  Grootslag 1-5, NL-3991 RA Houten, Nederland | EU/1/14/957 | Concentrate for solution for infusion | L01XC | 23.12.2014 |
| 19.12.2014 | Rixubis | Nonacog gamma | Baxter Innovations GmbH
  Industriestraße 67, A-1221 Wien, Österreich | EU/1/14/970 | Powder and solvent for solution for injection | B02BD04 | 23.12.2014 |
| 22.12.2014 | Scenesse | Afamelanotide | Clinuvel UK Limited
  c/o — Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom | EU/1/14/969 | Implant | D02BB02 | 29.12.2014 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

5.12.2014

Paliperidone Janssen

Paliperidone

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/14/971

Prolonged release suspension for injection

N05AX13

9.12.2014

8.12.2014

Duloxetine Lilly

Duloxetine

Eli Lilly Nederland B.V.

Grootslag 1-5, NL-3991 RA Houten, Nederland

EU/1/14/972

Gastro-resistant capsule, hard

N06AX21

10.12.2014

8.12.2014

Moventig

Naloxegol

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/962

Film-coated tablet

A06AH03

10.12.2014

16.12.2014

DUAVIVE

Oestrogens conjugated/bazedoxifene

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/14/960

Modified-release tablet

G03CX

18.12.2014

16.12.2014

Lynparza

Olaparib

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/959

Capsule, hard

L01

18.12.2014

19.12.2014

Cyramza

Ramucirumab

Eli Lilly Nederland B.V.

Grootslag 1-5, NL-3991 RA Houten, Nederland

EU/1/14/957

Concentrate for solution for infusion

L01XC

23.12.2014

19.12.2014

Rixubis

Nonacog gamma

Baxter Innovations GmbH

Industriestraße 67, A-1221 Wien, Österreich

EU/1/14/970

Powder and solvent for solution for injection

B02BD04

23.12.2014

22.12.2014

Scenesse

Afamelanotide

Clinuvel UK Limited

c/o — Reed Smith, Broadgate Tower, Third Floor, 20 Primrose Street, London, EC2A 2RS, United Kingdom

EU/1/14/969

Implant

D02BB02

29.12.2014

—   Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Modification of a marketing authorisation

Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 1.12.2014 | Desloratadine Teva | Teva Pharma B.V.
  Computerweg 10, NL-3542 DR Utrecht, Nederland | EU/1/11/732 | 3.12.2014 |
| 1.12.2014 | Ibandronic Acid Teva | Teva Pharma B.V.
  Computerweg 10, NL-3542 DR Utrecht, Nederland | EU/1/10/642 | 3.12.2014 |
| 1.12.2014 | Irbesartan Teva | Teva Pharma B.V.
  Computerweg 10, NL-3542 DR Utrecht, Nederland | EU/1/09/576 | 3.12.2014 |
| 1.12.2014 | Optimark | Mallinckrodt Deutschland GmbH
  Josef-Dietzgen-Strasse 1, D-53773 Hennef, Deutschland | EU/1/07/398 | 3.12.2014 |
| 4.12.2014 | Menveo | Novartis Vaccines and Diagnostics S.r.l.
  Via Fiorentina, 1, 53100 Siena, Italia | EU/1/10/614 | 9.12.2014 |
| 4.12.2014 | Ratiograstim | Ratiopharm GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/08/444 | 8.12.2014 |
| 4.12.2014 | Tevagrastim | Teva GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/08/445 | 8.12.2014 |
| 5.12.2014 | Cystagon | Orphan Europe S.A.R.L.
  Immeuble Le Wilson, 70 avenue du Général de Gaulle, F-92 800 Puteaux, France | EU/1/97/039 | 9.12.2014 |
| 5.12.2014 | Erbitux | Merck KGaA
  64271 Darmstadt, Deutschland | EU/1/04/281 | 9.12.2014 |
| 5.12.2014 | Vectibix | Amgen Europe B.V.
  Minervum 7061, NL-4817 ZK Breda, Nederland | EU/1/07/423 | 9.12.2014 |
| 11.12.2014 | Bronchitol | Pharmaxis Pharmaceuticals Limited
  The Priory, Stomp Road, Burnham, Buckinghamshire SL1 7LW, United Kingdom | EU/1/12/760 | 15.12.2014 |
| 11.12.2014 | Efavirenz Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/11/742 | 15.12.2014 |
| 11.12.2014 | Eviplera | Gilead Sciences International Limited
  Cambridge CB21 6GT, United Kingdom | EU/1/11/737 | 15.12.2014 |
| 11.12.2014 | Levetiracetam Ratiopharm | Ratiopharm GmbH
  Graf-Arco-Straße 3, D-89079 Ulm, Deutschland | EU/1/11/702 | 15.12.2014 |
| 11.12.2014 | Removab | Neovii Biotech GmbH
  Am Haag 6-7, 82166 Graefelfing, Deutschland | EU/1/09/512 | 15.12.2014 |
| 15.12.2014 | Lantus | Sanofi-Aventis Deutschland GmbH
  D-65926 Frankfurt am Main, Deutschland | EU/1/00/134 | 18.12.2014 |
| 15.12.2014 | Lemtrada | Genzyme Therapeutics Ltd
  4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford OX4 2SU, United Kingdom | EU/1/13/869 | 17.12.2014 |
| 15.12.2014 | Levetiracetam Actavis Group | Actavis Group PTC ehf.
  Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland | EU/1/11/738 | 18.12.2014 |
| 15.12.2014 | Mircera | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/07/400 | 18.12.2014 |
| 15.12.2014 | Naglazyme | BioMarin Europe Ltd
  164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom | EU/1/05/324 | 17.12.2014 |
| 15.12.2014 | Optisulin | Sanofi-Aventis Deutschland GmbH
  D-65926 Frankfurt am Main, Deutschland | EU/1/00/133 | 18.12.2014 |
| 15.12.2014 | Revestive | NPS Pharma Holdings Limited
  Grand Canal House, 1 Grand Canal Street Upper, Dublin 4, Ireland | EU/1/12/787 | 17.12.2014 |
| 15.12.2014 | Somatropin Biopartners | BioPartners GmbH
  Kaiserpassage 11, D-72764 Reutlingen, Deutschland | EU/1/13/849 | 17.12.2014 |
| 15.12.2014 | Tasigna | Novartis Europharm Limited
  Frimley Business Park, Camberley GU16 7SR, United Kingdom | EU/1/07/422 | 18.12.2014 |
| 15.12.2014 | Xeloda | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/00/163 | 18.12.2014 |
| 16.12.2014 | Afinitor | Novartis Europharm Limited
  Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/09/538 | 18.12.2014 |
| 16.12.2014 | Brintellix | H. Lundbeck A/S
  Ottiliavej 9, DK-2500 Valby, Danmark | EU/1/13/891 | 18.12.2014 |
| 16.12.2014 | Cimzia | UCB Pharma S.A.
  Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België | EU/1/09/544 | 17.12.2014 |
| 16.12.2014 | Fasturtec | Sanofi-Aventis groupe
  54 rue La Boétie, F-75008 Paris, France | EU/1/00/170 | 18.12.2014 |
| 16.12.2014 | Hizentra | CSL Behring GmbH
  Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland | EU/1/11/687 | 18.12.2014 |
| 16.12.2014 | HyQvia | Baxter Innovations GmbH
  Industriestraße 67, A-1221 Wien, Österreich | EU/1/13/840 | 18.12.2014 |
| 16.12.2014 | Incivo | Janssen-Cilag International NV
  Turnhoutseweg 30, B-2340 Beerse, België | EU/1/11/720 | 18.12.2014 |
| 16.12.2014 | Lamivudine Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/09/566 | 18.12.2014 |
| 16.12.2014 | Levetiracetam Actavis | Actavis Group PTC ehf.
  Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland | EU/1/11/713 | 18.12.2014 |
| 16.12.2014 | Methylthioninium chloride Proveblue | Provepharm S.A.S.
  22 Rue Marc Donadille, 13013 Marseille, France | EU/1/11/682 | 18.12.2014 |
| 16.12.2014 | NULOJIX | Bristol-Myers Squibb Pharma EEIG
  Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom | EU/1/11/694 | 18.12.2014 |
| 16.12.2014 | Orphacol | Laboratoires CTRS
  63 rue de l'Est, F-92100 Boulogne-Billancourt, France | EU/1/13/870 | 18.12.2014 |
| 16.12.2014 | Paglitaz | Krka, d. d., Novo Mesto
  Šmarješka cesta 6, 8501 Novo mesto, Slovenija | EU/1/11/721 | 18.12.2014 |
| 16.12.2014 | Pioglitazone Teva | Teva Pharma B.V.
  Computerweg 10, NL-3542 DR Utrecht, Nederland | EU/1/12/757 | 18.12.2014 |
| 16.12.2014 | Pioglitazone Teva Pharma | Teva Pharma B.V.
  Computerweg 10, NL-3542 DR Utrecht, Nederland | EU/1/12/758 | 18.12.2014 |
| 16.12.2014 | Remsima | Celltrion Healthcare Hungary Kft.
  Árpád Fejedelem útja 26-28, H-1023 Budapest, Magyarország | EU/1/13/853 | 18.12.2014 |
| 16.12.2014 | Ristaben | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/10/621 | 19.12.2014 |
| 16.12.2014 | Ristfor | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/10/620 | 17.12.2014 |
| 16.12.2014 | Stivarga | Bayer Pharma AG
  D-13342 Berlin, Deutschland | EU/1/13/858 | 18.12.2014 |
| 16.12.2014 | Ultibro Breezhaler | Novartis Europharm Limited
  Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/13/862 | 18.12.2014 |
| 16.12.2014 | Ulunar Breezhaler | Novartis Europharm Limited
  Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/14/917 | 19.12.2014 |
| 16.12.2014 | Votubia | Novartis Europharm Limited
  Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/11/710 | 18.12.2014 |
| 16.12.2014 | Xoterna Breezhaler | Novartis Europharm Limited
  Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom | EU/1/13/863 | 18.12.2014 |
| 16.12.2014 | Zelboraf | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/12/751 | 19.12.2014 |
| 19.12.2014 | CellCept | Roche Registration Limited
  6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom | EU/1/96/005 | 23.12.2014 |
| 19.12.2014 | InductOs | Medtronic BioPharma B.V.
  Earl Bakkenstraat 10, NL-6422 PJ Heerlen, Nederland | EU/1/02/226 | 23.12.2014 |
| 19.12.2014 | Puregon | Merck Sharp & Dohme Limited
  Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom | EU/1/96/008 | 23.12.2014 |
| 19.12.2014 | Rilutek | Aventis Pharma S.A.
  20 avenue Raymond Aron, F-92165 Antony CEDEX, France | EU/1/96/010 | 23.12.2014 |
| 19.12.2014 | Stayveer | Marklas Nederland B.V.
  Beneluxlaan 2b, NL-3446 GR Woerden, Nederland | EU/1/13/832 | 5.1.2015 |
| 19.12.2014 | Telmisartan Teva | Teva Pharma B.V.
  Computerweg 10, NL-3542 DR Utrecht, Nederland | EU/1/09/610 | 24.12.2014 |
| 19.12.2014 | Travatan | Alcon Laboratories (UK) Ltd
  Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom | EU/1/01/199 | 23.12.2014 |
| 19.12.2014 | Victoza | Novo Nordisk A/S
  Novo Allé, DK-2880 Bagsvaerd, Danmark | EU/1/09/529 | 23.12.2014 |
| 19.12.2014 | Zoledronic acid Teva | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/12/771 | 24.12.2014 |
| 19.12.2014 | Zoledronic acid Teva Pharma | Teva B.V.
  Swensweg 5, 2031 GA Haarlem, Nederland | EU/1/12/772 | 24.12.2014 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

1.12.2014

Desloratadine Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/11/732

3.12.2014

1.12.2014

Ibandronic Acid Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/10/642

3.12.2014

1.12.2014

Irbesartan Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/09/576

3.12.2014

1.12.2014

Optimark

Mallinckrodt Deutschland GmbH

Josef-Dietzgen-Strasse 1, D-53773 Hennef, Deutschland

EU/1/07/398

3.12.2014

4.12.2014

Menveo

Novartis Vaccines and Diagnostics S.r.l.

Via Fiorentina, 1, 53100 Siena, Italia

EU/1/10/614

9.12.2014

4.12.2014

Ratiograstim

Ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/08/444

8.12.2014

4.12.2014

Tevagrastim

Teva GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/08/445

8.12.2014

5.12.2014

Cystagon

Orphan Europe S.A.R.L.

Immeuble Le Wilson, 70 avenue du Général de Gaulle, F-92 800 Puteaux, France

EU/1/97/039

9.12.2014

5.12.2014

Erbitux

Merck KGaA

64271 Darmstadt, Deutschland

EU/1/04/281

9.12.2014

5.12.2014

Vectibix

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/07/423

9.12.2014

11.12.2014

Bronchitol

Pharmaxis Pharmaceuticals Limited

The Priory, Stomp Road, Burnham, Buckinghamshire SL1 7LW, United Kingdom

EU/1/12/760

15.12.2014

11.12.2014

Efavirenz Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/742

15.12.2014

11.12.2014

Eviplera

Gilead Sciences International Limited

Cambridge CB21 6GT, United Kingdom

EU/1/11/737

15.12.2014

11.12.2014

Levetiracetam Ratiopharm

Ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/11/702

15.12.2014

11.12.2014

Removab

Neovii Biotech GmbH

Am Haag 6-7, 82166 Graefelfing, Deutschland

EU/1/09/512

15.12.2014

15.12.2014

Lantus

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/00/134

18.12.2014

15.12.2014

Lemtrada

Genzyme Therapeutics Ltd

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford OX4 2SU, United Kingdom

EU/1/13/869

17.12.2014

15.12.2014

Levetiracetam Actavis Group

Actavis Group PTC ehf.

Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland

EU/1/11/738

18.12.2014

15.12.2014

Mircera

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/07/400

18.12.2014

15.12.2014

Naglazyme

BioMarin Europe Ltd

164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom

EU/1/05/324

17.12.2014

15.12.2014

Optisulin

Sanofi-Aventis Deutschland GmbH

D-65926 Frankfurt am Main, Deutschland

EU/1/00/133

18.12.2014

15.12.2014

Revestive

NPS Pharma Holdings Limited

Grand Canal House, 1 Grand Canal Street Upper, Dublin 4, Ireland

EU/1/12/787

17.12.2014

15.12.2014

Somatropin Biopartners

BioPartners GmbH

Kaiserpassage 11, D-72764 Reutlingen, Deutschland

EU/1/13/849

17.12.2014

15.12.2014

Tasigna

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/422

18.12.2014

15.12.2014

Xeloda

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/00/163

18.12.2014

16.12.2014

Afinitor

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/538

18.12.2014

16.12.2014

Brintellix

H. Lundbeck A/S

Ottiliavej 9, DK-2500 Valby, Danmark

EU/1/13/891

18.12.2014

16.12.2014

Cimzia

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/09/544

17.12.2014

16.12.2014

Fasturtec

Sanofi-Aventis groupe

54 rue La Boétie, F-75008 Paris, France

EU/1/00/170

18.12.2014

16.12.2014

Hizentra

CSL Behring GmbH

Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland

EU/1/11/687

18.12.2014

16.12.2014

HyQvia

Baxter Innovations GmbH

Industriestraße 67, A-1221 Wien, Österreich

EU/1/13/840

18.12.2014

16.12.2014

Incivo

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/11/720

18.12.2014

16.12.2014

Lamivudine Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/09/566

18.12.2014

16.12.2014

Levetiracetam Actavis

Actavis Group PTC ehf.

Reykjavíkurvegur 76-78, 220 Hafnarfjörður, Iceland

EU/1/11/713

18.12.2014

16.12.2014

Methylthioninium chloride Proveblue

Provepharm S.A.S.

22 Rue Marc Donadille, 13013 Marseille, France

EU/1/11/682

18.12.2014

16.12.2014

NULOJIX

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/11/694

18.12.2014

16.12.2014

Orphacol

Laboratoires CTRS

63 rue de l'Est, F-92100 Boulogne-Billancourt, France

EU/1/13/870

18.12.2014

16.12.2014

Paglitaz

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/11/721

18.12.2014

16.12.2014

Pioglitazone Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/12/757

18.12.2014

16.12.2014

Pioglitazone Teva Pharma

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/12/758

18.12.2014

16.12.2014

Remsima

Celltrion Healthcare Hungary Kft.

Árpád Fejedelem útja 26-28, H-1023 Budapest, Magyarország

EU/1/13/853

18.12.2014

16.12.2014

Ristaben

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/621

19.12.2014

16.12.2014

Ristfor

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/620

17.12.2014

16.12.2014

Stivarga

Bayer Pharma AG

D-13342 Berlin, Deutschland

EU/1/13/858

18.12.2014

16.12.2014

Ultibro Breezhaler

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/13/862

18.12.2014

16.12.2014

Ulunar Breezhaler

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/14/917

19.12.2014

16.12.2014

Votubia

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/11/710

18.12.2014

16.12.2014

Xoterna Breezhaler

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/13/863

18.12.2014

16.12.2014

Zelboraf

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/12/751

19.12.2014

19.12.2014

CellCept

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/96/005

23.12.2014

19.12.2014

InductOs

Medtronic BioPharma B.V.

Earl Bakkenstraat 10, NL-6422 PJ Heerlen, Nederland

EU/1/02/226

23.12.2014

19.12.2014

Puregon

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/96/008

23.12.2014

19.12.2014

Rilutek

Aventis Pharma S.A.

20 avenue Raymond Aron, F-92165 Antony CEDEX, France

EU/1/96/010

23.12.2014

19.12.2014

Stayveer

Marklas Nederland B.V.

Beneluxlaan 2b, NL-3446 GR Woerden, Nederland

EU/1/13/832

5.1.2015

19.12.2014

Telmisartan Teva

Teva Pharma B.V.

Computerweg 10, NL-3542 DR Utrecht, Nederland

EU/1/09/610

24.12.2014

19.12.2014

Travatan

Alcon Laboratories (UK) Ltd

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

EU/1/01/199

23.12.2014

19.12.2014

Victoza

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/09/529

23.12.2014

19.12.2014

Zoledronic acid Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/771

24.12.2014

19.12.2014

Zoledronic acid Teva Pharma

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/12/772

24.12.2014

—   Issuing of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Issuing of a marketing authorisation

Accepted

| Date of the decision | Name of the medicinal product | INN (International Non-Proprietary Name) | Holder of the marketing authorisation | Number of the entry in the Community Register | Pharmaceutical form | ATC code (Anatomical Therapeutic Chemical Code) | Date of notification |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 22.12.2014 | Bovela | Modified live BVDV-1, non-cytopathic parent strain KE-9, Modified live BVDV-2, non-cytopathic parent strain NY-93 | Boehringer Ingelheim International GmbH
  Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland | EU/2/14/176 | Lyophilisate and solvent for suspension for injection | QI02AD02 | 29.12.2014 |

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

22.12.2014

Bovela

Modified live BVDV-1, non-cytopathic parent strain KE-9, Modified live BVDV-2, non-cytopathic parent strain NY-93

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/2/14/176

Lyophilisate and solvent for suspension for injection

QI02AD02

29.12.2014

—   Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Modification of a marketing authorisation

Accepted

| Date of the decision | Name of the medicinal product | Holder of the marketing authorisation | Number of the entry in the Community Register | Date of notification |
| --- | --- | --- | --- | --- |
| 4.12.2014 | Gripovac 3 | Merial
  29 avenue Tony Garnier, F-69007 Lyon, France | EU/2/09/102 | 8.12.2014 |
| 4.12.2014 | Porcilis AR-T DF | Intervet International B.V.
  Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland | EU/2/00/026 | 8.12.2014 |
| 4.12.2014 | Respiporc Flu3 | IDT Biologika GmbH
  Am Pharmapark, D-06861 Dessau-Rosslau, Deutschland | EU/2/09/103 | 8.12.2014 |
| 11.12.2014 | Comfortis | Eli Lilly and Company Ltd, Elanco Animal Health
  Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom | EU/2/10/115 | 15.12.2014 |
| 11.12.2014 | Trifexis | Eli Lilly and Company Ltd, Elanco Animal Health
  Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom | EU/2/13/155 | 15.12.2014 |
| 16.12.2014 | Pexion | Boehringer Ingelheim Vetmedica GmbH
  D-55216 Ingelheim am Rhein, Deutschland | EU/2/12/147 | 18.12.2014 |

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

4.12.2014

Gripovac 3

Merial

29 avenue Tony Garnier, F-69007 Lyon, France

EU/2/09/102

8.12.2014

4.12.2014

Porcilis AR-T DF

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/00/026

8.12.2014

4.12.2014

Respiporc Flu3

IDT Biologika GmbH

Am Pharmapark, D-06861 Dessau-Rosslau, Deutschland

EU/2/09/103

8.12.2014

11.12.2014

Comfortis

Eli Lilly and Company Ltd, Elanco Animal Health

Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom

EU/2/10/115

15.12.2014

11.12.2014

Trifexis

Eli Lilly and Company Ltd, Elanco Animal Health

Lilly House Priestley Road, Basingstoke, Hampshire, RG24 9NL, United Kingdom

EU/2/13/155

15.12.2014

16.12.2014

Pexion

Boehringer Ingelheim Vetmedica GmbH

D-55216 Ingelheim am Rhein, Deutschland

EU/2/12/147

18.12.2014

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

| The European Medicines Agency |
| --- |
| 30, Churchill Place, Canary Wharf |
| UK — LONDON E14 5EU |

The European Medicines Agency

30, Churchill Place, Canary Wharf

UK — LONDON E14 5EU

---

(1)  OJ L 136, 30.4.2004, p. 1.

1

---